Revolutionizing cardiac fibrosis treatment: the potential of personalized CAR T-cell therapy
Abstract Cardiac fibrosis, a condition characterized by the deposition of excess collagen in the cardiac tissue, is a major complication of various cardiovascular diseases, including myocardial infarction, hypertension, and different types of cardiomyopathies. CAR T-cell therapy, a form of immunothe...
Saved in:
| Main Authors: | Soroush Taherkhani, Maryam Honardoost, Negar Dokhani, Atousa Janzadeh |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-08-01
|
| Series: | Cardio-Oncology |
| Online Access: | https://doi.org/10.1186/s40959-025-00367-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAR-T Cell Therapy: Revolutionizing Cancer Treatment
by: Kirolos Eskandar, et al.
Published: (2024-02-01) -
CAR-T Cell Therapy: Managing Side Effects and Overcoming Challenges
by: Maryam Golmohammadi, et al.
Published: (2025-04-01) -
Emerging Epigenetic Therapies for the Treatment of Cardiac Fibrosis
by: Nerea Garitano, et al.
Published: (2025-05-01) -
Radiosensitising effect of iron oxide‐gold nanocomplex for electron beam therapy of melanoma in vivo by magnetic targeting
by: Mahshad Mohamadkazem, et al.
Published: (2023-05-01) -
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
by: Liu X, et al.
Published: (2025-06-01)